Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vaxcyte (PCVX) Exchange Rate Effect (2021 - 2026)

Vaxcyte (PCVX) has 6 years of Exchange Rate Effect data on record, last reported at -$664000.0 in Q1 2026.

  • On a quarterly basis, Exchange Rate Effect fell 156.66% to -$664000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $603000.0, a 113.51% increase, with the full-year FY2025 number at $2.4 million, up 472.54% from a year prior.
  • Exchange Rate Effect reached -$664000.0 in Q1 2026 per PCVX's latest filing, down from $176000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for PCVX hit a ceiling of $6.1 million in Q1 2024 and a floor of -$7.7 million in Q4 2023.
  • A 5-year average of -$255764.7 and a median of $53000.0 in 2022 define the central range for Exchange Rate Effect.
  • On a YoY basis, Exchange Rate Effect climbed as much as 26256.52% in 2024 and fell as far as 1707.69% in 2024.
  • Tracing PCVX's Exchange Rate Effect over 5 years: stood at $796000.0 in 2022, then plummeted by 1065.08% to -$7.7 million in 2023, then soared by 117.57% to $1.3 million in 2024, then tumbled by 86.96% to $176000.0 in 2025, then crashed by 477.27% to -$664000.0 in 2026.
  • Business Quant data shows Exchange Rate Effect for PCVX at -$664000.0 in Q1 2026, $176000.0 in Q4 2025, and $291000.0 in Q3 2025.